These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35842792)

  • 1. Hemodynamic response and safety of vasodilator stress cardiovascular magnetic resonance in patients with permanent pacemakers or implantable cardioverter-defibrillators.
    Miller L; Airapetov S; Pillai A; Kalahasty G; Ellenbogen KA; Gregory Hundley W; Trankle CR
    J Cardiovasc Electrophysiol; 2022 Oct; 33(10):2127-2135. PubMed ID: 35842792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deactivation vs. asynchronous pacing - prospective evaluation of a protocol for rhythm management in patients with magnetic resonance conditional pacemakers undergoing adenosine stress cardiovascular magnetic resonance imaging.
    Klein-Wiele O; Garmer M; Barbone G; Urbien R; Busch M; Kara K; Schäfer H; Schulte-Hermes M; Hailer B; Grönemeyer D
    BMC Cardiovasc Disord; 2017 Jun; 17(1):142. PubMed ID: 28577544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of adenosine stress cardiovascular magnetic resonance perfusion imaging in patients with MR-conditional transvenous permanent pacemakers and defibrillators.
    Pavon AG; Porretta AP; Arangalage D; Domenichini G; Rutz T; Hugelshofer S; Pruvot E; Monney P; Pascale P; Schwitter J
    J Cardiovasc Magn Reson; 2022 Jan; 24(1):9. PubMed ID: 35022037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and safety of adenosine cardiovascular magnetic resonance in patients with MR conditional pacemaker systems at 1.5 Tesla.
    Klein-Wiele O; Garmer M; Urbien R; Busch M; Kara K; Mateiescu S; Grönemeyer D; Schulte-Hermes M; Garbrecht M; Hailer B
    J Cardiovasc Magn Reson; 2015 Dec; 17():112. PubMed ID: 26695427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of cardiovascular magnetic resonance with optimized myocardial scar detection in patients with cardiac implantable devices.
    Bhuva AN; Kellman P; Graham A; Ramlall M; Boubertakh R; Feuchter P; Hawkins A; Lowe M; Lambiase PD; Sekhri N; Schilling RJ; Moon JC; Manisty CH
    Int J Cardiol; 2019 Mar; 279():72-78. PubMed ID: 30642645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac magnetic resonance imaging using wideband sequences in patients with nonconditional cardiac implanted electronic devices.
    Do DH; Eyvazian V; Bayoneta AJ; Hu P; Finn JP; Bradfield JS; Shivkumar K; Boyle NG
    Heart Rhythm; 2018 Feb; 15(2):218-225. PubMed ID: 29017930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: best practice and real-world experience.
    Seewöster T; Löbe S; Hilbert S; Bollmann A; Sommer P; Lindemann F; Bacevičius J; Schöne K; Richter S; Döring M; Paetsch I; Hindricks G; Jahnke C
    Europace; 2019 Aug; 21(8):1220-1228. PubMed ID: 31131393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of pacemakers and implantable cardioverter defibrillators in urological practice.
    Ubee SS; Kasi VS; Bello D; Manikandan R
    J Urol; 2011 Oct; 186(4):1198-205. PubMed ID: 21849189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR.
    Muñiz-Sáenz-Diez J; Ezponda A; Caballeros M; de la Fuente A; Gavira JJ; Bastarrika G
    Int J Cardiovasc Imaging; 2023 Sep; 39(9):1765-1774. PubMed ID: 37354385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and prognostic value of regadenoson stress cardiovascular magnetic resonance imaging in heart transplant recipients.
    Kazmirczak F; Nijjar PS; Zhang L; Hughes A; Chen KA; Okasha O; Martin CM; Akçakaya M; Farzaneh-Far A; Shenoy C
    J Cardiovasc Magn Reson; 2019 Jan; 21(1):9. PubMed ID: 30674318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla.
    Nazarian S; Roguin A; Zviman MM; Lardo AC; Dickfeld TL; Calkins H; Weiss RG; Berger RD; Bluemke DA; Halperin HR
    Circulation; 2006 Sep; 114(12):1277-84. PubMed ID: 16966586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging in patients with cardiac implantable electronic devices: a single-center prospective study.
    Yadava M; Nugent M; Krebsbach A; Minnier J; Jessel P; Henrikson CA
    J Interv Card Electrophysiol; 2017 Oct; 50(1):95-104. PubMed ID: 28733766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 T.
    Naehle CP; Kreuz J; Strach K; Schwab JO; Pingel S; Luechinger R; Fimmers R; Schild H; Thomas D
    Am Heart J; 2011 Jun; 161(6):1096-105. PubMed ID: 21641356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety of magnetic resonance imaging in patients with pacemaker and implantable defibrillator].
    Al-Sabagh KH; Christensen BE; Thøgersen AM; Petersen HH; Videbaek R; Pehrson S; Chen X; Thomsen C; Svendsen JH
    Ugeskr Laeger; 2010 Jun; 172(23):1740-4. PubMed ID: 20534201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences of magnetic resonance imaging scanning in patients with pacemakers or implantable cardioverter-defibrillators.
    Han D; Kang SH; Cho Y; Oh IY
    Korean J Intern Med; 2019 Jan; 34(1):99-107. PubMed ID: 29609452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular magnetic resonance in patients with magnetic resonance conditional pacemaker systems at 1.5 T: influence of pacemaker related artifacts on image quality including first pass perfusion, aortic and mitral valve assessment, flow measurement, short tau inversion recovery and T1-weighted imaging.
    Klein-Wiele O; Garmer M; Busch M; Mateiescu S; Urbien R; Barbone G; Kara K; Schulte-Hermes M; Metz F; Hailer B; Grönemeyer D
    Int J Cardiovasc Imaging; 2017 Mar; 33(3):383-394. PubMed ID: 27815793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators.
    Sasaki T; Hansford R; Zviman MM; Kolandaivelu A; Bluemke DA; Berger RD; Calkins H; Halperin HR; Nazarian S
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):662-70. PubMed ID: 21946701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopy in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan.
    Mollerus M; Albin G; Lipinski M; Lucca J
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):772-8. PubMed ID: 19545340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Safety of Cardiac and Thoracic Magnetic Resonance Imaging in Patients with Cardiac Implantable Electronic Devices.
    Dandamudi S; Collins JD; Carr JC; Mongkolwat P; Rahsepar AA; Tomson TT; Verma N; Arora R; Chicos AB; Kim SS; Lin AC; Passman RS; Knight BP
    Acad Radiol; 2016 Dec; 23(12):1498-1505. PubMed ID: 27717762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing cardiac implantable electronic device-induced artefacts in cardiac magnetic resonance imaging.
    Vuorinen AM; Lehmonen L; Karvonen J; Holmström M; Kivistö S; Kaasalainen T
    Eur Radiol; 2023 Feb; 33(2):1229-1242. PubMed ID: 36029346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.